Highlights Elutia Inc.

Equities

ELUT

US05479K1060

Market Closed - Nasdaq Other stock markets 21:30:01 14/05/2024 BST			5-day change	1st Jan Change
3.34 ^USD	-2.34%		+15.17%	+54.63%

05-09	Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-09	Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	05-09	MT
Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-07	CI
Elutia Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-07	CI
Earnings Flash (ELUT) ELUTIA Posts Q4 Revenue $5.9M, vs. Street Est of $6.6M	03-07	MT
Elutia Submits CanGaroo Antibiotic-Eluting Biomatrix for FDA Clearance	12-18	CI
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Earnings Flash (ELUT) ELUTIA Reports Q3 Revenue $6.1M, vs. Street Est of $7.3M	11-13	MT
Berkeley Biologics, LLC completed the acquisition of Orthobiologics business unit of Elutia Inc. for $34.6 million.	11-07	CI
GNI Group Plans to Buy Portion of Elutia's Orthobiologics Business	20/09/23	MT
North American Morning Briefing : Stock Futures Lack Momentum as Fed Decision Looms	19/09/23	DJ
Elutia Sells Orthobiologics Business Unit For Up to $35 Million	18/09/23	MT
Berkeley Biologics, LLC entered into an Asset Purchase Agreement Orthobiologics business unit of Elutia Inc. for $35 million.	17/09/23	CI
Aziyo Biologics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Earnings Flash (AZYO) AZIYO BIOLOGICS Posts Q2 Revenue $10.3M, vs. Street Est of $12.5M	14/08/23	MT
Aziyo Biologics Voluntarily Recalls Bone-Repair Products	13/07/23	MT
Aziyo Biologics, Inc. Announces the Voluntary Recall of Its Viable Bone Matrix Products	13/07/23	CI
Aziyo Biologics, Inc. Presents Positive Clinical Data on Cangaroo® Biologic Envelope	19/05/23	CI
Aziyo Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio	21/04/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Elutia Inc.

Equities

ELUT

US05479K1060

Highlights

Filters